Fundraising FoxRed Tree Venture — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
BiotechSan Francisco, US
Donald Manning(Executive Officer)Scott Harris(Executive Officer)Julien Mamet(Executive Officer, Director)Rick Orr(Executive Officer, Director)
BoardDennis Podlesak(Director)inEckard Weber(Director)
Board seatHeath Lukatch· per SEC Form D · $16M raise · filed Jan 2017
Co-investorsDomain Associates
Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).
BiotechHealthtechMedical DevicesSouth San Francisco, US
John Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)Thomas B. King(President and Board Director)inRob Janosky(Chief Commercial Officer)Tom O'Neil(Chief Financial Officer)inDavid Prichard(Chief Operating Officer)
Board seatHeath Lukatch· per SEC Form D · $12.3M raise · filed Feb 2018
Co-investorsOUP (Osage University Partners)Vivo CapitalWellington ManagementLumira VenturesRA CapitalSBI Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.